Summer Special! Get NewsNow Essentials at just £2.99 a month (25% OFF!). Faster, slicker, customisable & ad free!Summer Special! Get NewsNow Essentials at just £2.99 a month (25% OFF!). Subscribe and saveSummer Special! Upgrade here at £2.99/m (25% OFF!)

Home
Hot Topics
US
Politics
World
Sports
Business
Crypto
Entertainment
Lifestyle
Tech
Science

Eli Lilly
Pharmaceuticals
Mounjaro
AstraZeneca
Novo Nordisk
Sanofi
Pfizer
Teva
GSK
Johnson & Johnson
Topics

Advertisement

Eli Lilly

Share

Top Latest Popular

In the last 4 hours

Eli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official -- and Novo Nordisk Has a Problem The Motley Fool 23:40 Fri, 07 Aug

In the last 6 hours

Eli Lilly Launches Attacks Of Tirzepatide Generics Law360 21:06 Fri, 07 Aug

Pfizer's Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk's Wegovy and Eli Lilly's Zepbound The Motley Fool 20:36 Fri, 07 Aug

Advertisement

Advertisement

Yesterday

CVS Health (CVS) Is Down 8.6% After Raising EPS Outlook And Expanding GLP-1 Offerings - Has The Bull Case Changed? Simply Wall St 08:42 Fri, 07 Aug

Will Strong Q2 Results and Higher 2026 Outlook Change Eli Lilly's (LLY) Narrative? Simply Wall St 08:42 Fri, 07 Aug

Thursday

Eli Lilly, Novo Nordisk Antitrust Suit Tossed By Texas Judge Law360 20:19 Thu, 06 Aug

Eli Lilly Earnings: Strong Q2 and Higher Margin Expectations MorningStar.com 15:39 Thu, 06 Aug

The Next Billion-Dollar Opportunity in Alzheimer's Disease Market: 6 Pipeline Therapies to Watch | DelveInsight PR Newswire (Press Release) 15:33 Thu, 06 Aug

Eli Lilly Stock: Analyst Estimates & Ratings Barchart 11:27 Thu, 06 Aug

Eli Lilly raises 2026 outlook again as Q2 soars past estimates Pharmaceutical Technology 11:19 Thu, 06 Aug

AI tool aims to accelerate Alzheimer's treatment through faster referrals News-Medical.Net 04:12 Thu, 06 Aug

Wednesday

Why Eli Lilly Stock Climbed Today The Motley Fool 23:42 Wed, 05 Aug

Eli Lilly’s Obesity Drugs Drive Massive Revenue Growth Forbes 22:20 Wed, 05 Aug

LLY Stock Alert: What to Know as Eli Lilly Teams Up With CVS on Weight-Loss Drugs Barchart 21:00 Wed, 05 Aug

Revive Rx Can't End Eli Lilly's Suit Over Tirzepatide Drugs Law360 20:24 Wed, 05 Aug

Team’s AI agent to speed Alzheimer’s treatment Newswise (Press Release) 20:09 Wed, 05 Aug

Advertisement

GLP-1 drugs are driving higher sales for Eli Lilly and Novo Nordisk Global News 20:08 Wed, 05 Aug

Eli Lilly raises annual revenue expectation as GLP-1 drugs fuel growth The Business Standard 20:04 Wed, 05 Aug

Market movers: Shopify, Uber, Eli Lilly, SolarEdge, CVS Health… Proactive Investors (Canada) 19:32 Wed, 05 Aug

Everything is good in the markets for earnings: David Bahnsen Fox News 18:24 Wed, 05 Aug

Stock Market Midday, Aug. 5: Eli Lilly Pops and AMD Drops in Mixed Morning Markets The Motley Fool 17:56 Wed, 05 Aug

Novo Nordisk not currently in a position to pursue large-scale M&A, CEO says Pharmaceutical Technology 17:22 Wed, 05 Aug

Eli Lilly's Weight-Loss Empire Keeps Expanding As Mounjaro, Zepbound Generate Nearly $15 Billion Benzinga 17:11 Wed, 05 Aug

Nasdaq Falls Over 100 Points; Eli Lilly Shares Gain On Upbeat Earnings Benzinga 17:01 Wed, 05 Aug

CVS Targets Affordable GLP-1 Access With New Eli Lilly Deal Benzinga 16:20 Wed, 05 Aug

Drug Compounder Loses Bid to Toss Lilly’s Suit Over GLP-1 Copies Bloomberg Law 16:19 Wed, 05 Aug

Eli Lilly Raises Sales Forecast As Weight Loss Drug Demand Soars. Its Stock is Climbing IBTimes (US) 16:08 Wed, 05 Aug

Michigan Supreme Court Expands Consumer Protection Act JD Supra 15:53 Wed, 05 Aug

Eli Lilly stock surges 6% after Q2 earnings beat driven by Mounjaro, Zepbound Invezz 15:30 Wed, 05 Aug

Eli Lilly And Company Stock Rises 6% Over Strong Q2 Results RTT News 15:23 Wed, 05 Aug

Eli Lilly shares rise on revenue beat, raised outlook Proactive Investors (US) 14:52 Wed, 05 Aug

Sales in weight-loss drug Mounjaro double amid surging market appetite The Independent 14:38 Wed, 05 Aug

Eli Lilly (LLY) Q2 Earnings and Revenues Surpass Estimates Zacks 14:21 Wed, 05 Aug

Lilly boosts guidance on strong demand for obesity drugs Irish Examiner 14:02 Wed, 05 Aug

Mounjaro sales double this year as obesity drug boom prevails, says maker Evening Standard 13:44 Wed, 05 Aug

Eli Lilly lifts FY guidance as Mounjaro, Zepbound drive Q2 sales ShareCast 13:43 Wed, 05 Aug

Lilly's GLP-1s race away in Q2, though Foundayo falls short pharmaphorum 13:40 Wed, 05 Aug

Dow Jones and S&P 500 set to notch new highs despite AMD and SpaceX falls Proactive Investors (US) 13:21 Wed, 05 Aug

Eli Lilly ups revenue forecast as GLP-1 drugs fuel growth RTE 12:56 Wed, 05 Aug

Eli Lilly raises annual revenue forecast as GLP-1 drugs fuel growth BNN Bloomberg 12:54 Wed, 05 Aug

Advertisement

Advertisement

About our Eli Lilly news

Latest news on on Eli Lilly and Company, an American pharmaceutical with headquarters in Indianapolis.

News Now

Our Sites

News Now Nigeria

News Now România

News Now Italia

News Now Canada

News Now Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Business Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Takeda Takeda
- Teva Teva
- Zoetis Zoetis